MedPath

University Of California, San Francisco

πŸ‡ΊπŸ‡ΈUnited States
Ownership
-
Employees
-
Market Cap
-
Website

An Adaptive Strategy for Preventing and Treating Lapses of Retention in Adult HIV Care (AdaPT-R) in Nyanza, Kenya

Not Applicable
Completed
Conditions
HIV
Interventions
Behavioral: REC; SMS + Voucher if Failure
Behavioral: REC; Navigator if Failure
Behavioral: SMS; Navigator if Failure
Behavioral: SMS; Outreach if Failure
Behavioral: SMS; Navigator if Failure; Stop SMS if Success
Behavioral: REC; Outreach if Failure
Behavioral: SMS; SMS+Voucher if Failure
Behavioral: Voucher; Outreach if Failure; Stop Voucher if Success
Behavioral: Voucher; Navigator if Failure; Stop Voucher if Success
Behavioral: SMS; SMS+Voucher if Failure; Stop SMS if Success
Behavioral: Voucher; Outreach if Failure
Behavioral: Voucher; SMS+Voucher if Failure
Behavioral: Voucher; SMS+Voucher if Failure; Stop Voucher if Success
Behavioral: SMS; Outreach if Failure; Stop SMS if Success
Behavioral: Voucher; Navigator if Failure
First Posted Date
2015-01-14
Last Posted Date
2021-03-16
Lead Sponsor
University of California, San Francisco
Target Recruit Count
1816
Registration Number
NCT02338739
Locations
πŸ‡°πŸ‡ͺ

Kenya Medical Research Institute, Kisumu, Nyanza, Kenya

MoTHER Buddy Program

Not Applicable
Completed
Conditions
Obesity
Physical Activity
Interventions
Behavioral: mHealth Physical Activity
Behavioral: Buddy-partnered exercise
First Posted Date
2015-01-14
Last Posted Date
2016-06-10
Lead Sponsor
University of California, San Francisco
Target Recruit Count
54
Registration Number
NCT02338765
Locations
πŸ‡ΊπŸ‡Έ

University of California, San Francisco, San Francisco, California, United States

Better Than Study: Targeting Heavy Alcohol Use With Naltrexone Among Men Who Have Sex With Men (MSM)

Phase 2
Completed
Conditions
Binge Drinking
HIV
Interventions
Drug: Placebo
Diagnostic Test: Dried Blood Spot (DSB) Testing for Phosphatidylethanol
Behavioral: Ecological Momentary Assessment
First Posted Date
2015-01-05
Last Posted Date
2025-04-20
Lead Sponsor
University of California, San Francisco
Target Recruit Count
120
Registration Number
NCT02330419
Locations
πŸ‡ΊπŸ‡Έ

Center on Substance Use and Health, San Francisco, California, United States

Prenatal Education About Reducing Labor Stress (PEARLS)

Not Applicable
Completed
Conditions
Labor Pain
Tocophobia
Interventions
Behavioral: Treatment as usual (TAU)
First Posted Date
2014-12-30
Last Posted Date
2017-05-25
Lead Sponsor
University of California, San Francisco
Target Recruit Count
33
Registration Number
NCT02327559
Locations
πŸ‡ΊπŸ‡Έ

The Osher Center for Integrative Medicine, San Francisco, California, United States

Randomized Controlled Trial of Interpersonal Psychotherapy for Depression and PTSD Among HIV+ Women in Kenya

Not Applicable
Completed
Conditions
Depression
Posttraumatic Stress Disorder
HIV
Interventions
Behavioral: treatment as usual
Behavioral: interpersonal psychotherapy
First Posted Date
2014-12-19
Last Posted Date
2019-05-01
Lead Sponsor
University of California, San Francisco
Target Recruit Count
300
Registration Number
NCT02320799
Locations
πŸ‡°πŸ‡ͺ

Family AIDS Care Education and Services, Kisumu, Nyanza, Kenya

A Study to Determine Serum and Skin Biopsy Biomarkers in Patients Receiving Topical Corticosteroid (TCS) and Following TCS Withdrawal

Phase 4
Terminated
Conditions
Dermatitis, Atopic
Interventions
First Posted Date
2014-12-15
Last Posted Date
2019-01-24
Lead Sponsor
University of California, San Francisco
Target Recruit Count
11
Registration Number
NCT02317276
Locations
πŸ‡ΊπŸ‡Έ

UCSF Dermatology, San Francisco, California, United States

Evaluation of Reactive Focal Mass Drug Administration for Malaria Elimination in Swaziland

Phase 3
Completed
Conditions
Malaria
Interventions
Procedure: reactive case detection
Drug: dihydroartemisinin-piperaquine (DHAp)
First Posted Date
2014-12-12
Last Posted Date
2021-09-05
Lead Sponsor
University of California, San Francisco
Target Recruit Count
4000
Registration Number
NCT02315690
Locations
πŸ‡ΈπŸ‡Ώ

Swaziland Ministry of Health, Mbabane, Swaziland

Bevacizumab Therapy for Brain Arteriovenous Malformation

Phase 1
Completed
Conditions
Brain Arteriovenous Malformation
Interventions
First Posted Date
2014-12-11
Last Posted Date
2020-03-03
Lead Sponsor
University of California, San Francisco
Target Recruit Count
2
Registration Number
NCT02314377
Locations
πŸ‡ΊπŸ‡Έ

University of California San Francisco, San Francisco, California, United States

Early Limited Formula for Treating Lactation Concerns

Not Applicable
Completed
Conditions
Breastfeeding
Interventions
Other: Standard Care
Other: Early Limited Formula
First Posted Date
2014-12-09
Last Posted Date
2018-05-03
Lead Sponsor
University of California, San Francisco
Target Recruit Count
328
Registration Number
NCT02313181
Locations
πŸ‡ΊπŸ‡Έ

Penn State Hershey Medical Center, Hershey, Pennsylvania, United States

πŸ‡ΊπŸ‡Έ

University of California, San Francisco Medical Center, San Francisco, California, United States

Administration of Follicle-stimulating Hormone (FSH) and Low Dose Human Chorionic Gonadotropin (hCG) for Oocyte Maturity While Decreasing hCG Exposure in In Vitro Fertilization (IVF) Cycles

Phase 3
Completed
Conditions
Infertility
Interventions
Drug: Standard dose of hCG
Drug: Low dose hCG plus FSH co-trigger
First Posted Date
2014-12-08
Last Posted Date
2022-04-29
Lead Sponsor
University of California, San Francisco
Target Recruit Count
105
Registration Number
NCT02310919
Locations
πŸ‡ΊπŸ‡Έ

University of California at San Francisco, San Francisco, California, United States

Β© Copyright 2025. All Rights Reserved by MedPath